Stereotaxis Inc (STXS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Stereotaxis Inc (STXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010836
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stereotaxis Inc (Stereotaxis) is a healthcare technology company that designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch Solution is an advanced remote robotic navigation system for use in interventional lab for the treatment of arrhythmias and coronary artery disease. The Epoch Solution consists of Niobe ES robotic magnetic navigation system, Odyssey information management solution and Vdrive robotic navigation system. It also offers maintenance and support services for its integrated products. The company markets its products and services through direct sales force and through strategic alliances with other companies in the US, Europe and other parts of the world. Stereotaxis is headquartered in St. Louis, Missouri, the US.

Stereotaxis Inc (STXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stereotaxis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Stereotaxis Inc, Medical Devices Deals, 2011 to YTD 2017 9
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Stereotaxis Amends Co-Development Agreement With Biosense Webster 11
Equity Offering 12
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 12
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 13
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 14
Stereotaxis Completes Private Placement Of Shares For US$10 Million 15
Stereotaxis Inc – Key Competitors 16
Stereotaxis Inc – Key Employees 17
Stereotaxis Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 19
Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 21
May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 22
Nov 07, 2016: Stereotaxis Reports 2016 Third Quarter Financial Results 23
Aug 09, 2016: Stereotaxis Reports 2016 Second Quarter Financial Results 25
May 09, 2016: Stereotaxis Reports 2016 First Quarter Financial Results 27
Corporate Communications 28
Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 28
Sep 27, 2016: Stereotaxis Announces Recruitment of Highly Experienced Board Members 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Stereotaxis Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stereotaxis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stereotaxis Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Stereotaxis Inc, Medical Devices Deals, 2011 to YTD 2017 9
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Stereotaxis Amends Co-Development Agreement With Biosense Webster 11
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 12
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 13
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 14
Stereotaxis Completes Private Placement Of Shares For US$10 Million 15
Stereotaxis Inc, Key Competitors 16
Stereotaxis Inc, Key Employees 17
Stereotaxis Inc, Other Locations 18
Stereotaxis Inc, Subsidiaries 18

★海外企業調査レポート[Stereotaxis Inc (STXS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ittehad Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Ittehad Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tyson Foods Inc:企業の戦略・SWOT・財務情報
    Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Jacobs Engineering Group Inc (JEC):企業の財務・戦略的SWOT分析
    Jacobs Engineering Group Inc (JEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • EnerMech Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary EnerMech Ltd (EnerMech) is a provider of oilfield services. The company offers cranes and lifting services, hydraulic products and services, pipeline and umbilicals services, valve services, equipment rental, training services and industrial services. Its pipeline and umbilical services comp …
  • Saint-Gobain Ltd:企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務情報
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sun Resources NL (SUR):企業の財務・戦略的SWOT分析
    Summary Sun Resources NL (Sun Resources) is an oil and gas exploration and development company. The company explores and develops crude oil and natural gas. Its services include exploration, production, and development of unconventional oil and gas resources. Its projects include Delta Oil Project, …
  • PT PAL Indonesia:企業の戦略・SWOT・財務情報
    PT PAL Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT PAL Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Laboratorios LETI SL:企業の戦略的SWOT分析
    Laboratorios LETI SL - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • BioDot Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioDot Inc (BioDot) is a non-contact and quantitative fluid dispensing system manufacturer. The company’s application comprises rapid test, cytogenetics and life science. It provides lateral flow, immunoblots, dry chemistry, low volume PCR, bio chips, biosensors, fish, karyotyping and LIS in …
  • Yanzhou Coal Mining Co Ltd:戦略・SWOT・企業財務分析
    Yanzhou Coal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanzhou Coal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hikal Ltd (HIKAL):企業の財務・戦略的SWOT分析
    Summary Hikal Ltd (Hikal) is a pharmaceutical company that provides custom manufacturing; active ingredients and intermediates. The company provides product portfolio such as antiepileptic, antihistamine, antipsychotic and antilipemic, among others. It offers services such as custom synthesis, contr …
  • Versantis AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Versantis AG (Versantis) is a pharmaceutical company that develops new generation of medicines and diagnostics for treating patients with liver diseases. The company’s pipeline product includes VS-01, a liposomal-based peritoneal dialysis fluid that acts as a clearance enhancer for a large s …
  • Danaher Corporation (DHR)-医療機器分野:企業M&A・提携分析
    Summary Danaher Corporation (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. The company offers a wide range of testing instruments, communications solutions, water quality systems, medical diagn …
  • Clarivate Plc (CLVT):企業の財務・戦略的SWOT分析
    Clarivate Plc (CLVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sihayo Gold Ltd:企業の戦略・SWOT・財務分析
    Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • University of Pittsburgh Medical Center:企業の戦略的SWOT分析
    University of Pittsburgh Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Hunt Oil Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Hunt Oil Co (Hunt Oil), a subsidiary Hunt Consolidated, Inc., is an independent upstream company. It carries out exploration, production and development of oil and natural gas. In the US, it has acreage and active programs in the Williston Basin (Bakken) of North Dakota, the Permian Basin of …
  • 4P-Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary 4P-Pharma SAS (4P-Pharma) is a drug development company that offers drug pipeline for cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therap …
  • Samsung SDI Co Ltd (006400):電力:M&Aディール及び事業提携情報
    Summary Samsung SDI Co., Ltd. (Samsung SDI) is a global manufacturer and distributor of the batteries. The company along with its subsidiaries carries out research and development, manufacturing, and marketing of a wide range of digital products such as small size Li-ion battery, automotive battery, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆